KAS
BIIB icon

Kestra Advisory Services’s Biogen BIIB Stock Holding History

Kestra Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.07M Buy
5,810
+1,301
+29% +$240K ﹤0.01% 1685
2025
Q4 		$794K Buy
4,509
+2,387
+112% +$390K ﹤0.01% 1823
2025
Q3 		$297K Sell
2,122
-105
-5% -$14.2K ﹤0.01% 2452
2025
Q2 		$280K Buy
2,227
+314
+16% +$39.1K ﹤0.01% 2406
2025
Q1 		$262K Sell
1,913
-236
-11% -$33.7K ﹤0.01% 2269
2024
Q4 		$329K Sell
2,149
-107
-5% -$18K ﹤0.01% 2158
2024
Q3 		$437K Sell
2,256
-662
-23% -$138K ﹤0.01% 1853
2024
Q2 		$676K Buy
2,918
+28
+1% +$6.08K ﹤0.01% 1583
2024
Q1 		$623K Buy
2,890
+119
+4% +$27.9K ﹤0.01% 1520
2023
Q4 		$717K Buy
2,771
+113
+4% +$27.8K 0.01% 1301
2023
Q3 		$683K Sell
2,658
-371
-12% -$99.2K 0.01% 1199
2023
Q2 		$863K Buy
3,029
+750
+33% +$223K 0.01% 1049
2023
Q1 		$634K Sell
2,279
-6,163
-73% -$1.71M 0.01% 1161
2022
Q4 		$2.34M Sell
8,442
-109
-1% -$30.8K 0.02% 686
2022
Q3 		$2.28M Sell
8,551
-491
-5% -$104K 0.02% 621
2022
Q2 		$1.84M Sell
9,042
-410
-4% -$83.8K 0.02% 703
2022
Q1 		$1.99M Buy
9,452
+2,190
+30% +$476K 0.02% 677
2021
Q4 		$1.74M Sell
7,262
-4,888
-40% -$1.26M 0.02% 745
2021
Q3 		$3.44M Sell
12,150
-2,346
-16% -$769K 0.03% 516
2021
Q2 		$5.02M Buy
14,496
+525
+4% +$159K 0.06% 361
2021
Q1 		$3.91M Buy
13,971
+9,462
+210% +$2.55M 0.05% 387
2020
Q4 		$1.1M Buy
4,509
+4,483
+17,242% +$1.16M 0.01% 833
2020
Q3 		$633K Buy
+26
New +$7.25K 0.01% 788

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kestra Advisory Services's BIIB Position: Q1 2026 in Review

Kestra Advisory Services increased its Biogen (BIIB) stake by 29% in Q1 2026, buying an estimated $240K and bringing the position to 5,810 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Kestra Advisory Services first reported a position in BIIB in Q3 2020 and has held it in 23 quarters since. The position peaked at $5.02M in Q2 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Kestra Advisory Services held 5,810 shares of Biogen worth $1.07M as of Q1 2026.
  • Kestra Advisory Services bought 1,301 Biogen shares in Q1 2026, an estimated $240K.
  • Biogen made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #1685 holding.
  • Kestra Advisory Services first reported a position in Biogen in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's Biogen position peaked at $5.02M in Q2 2021.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.